Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 5
2019 1
2020 2
2021 3
2022 1
2023 4
2024 3
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis.
Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Zamorano L, Oliver A; GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group. Sastre-Femenia MÀ, et al. Lancet Reg Health Eur. 2023 Sep 19;34:100736. doi: 10.1016/j.lanepe.2023.100736. eCollection 2023 Nov. Lancet Reg Health Eur. 2023. PMID: 37753216 Free PMC article.
Spanish nationwide survey of Pseudomonas aeruginosa cefiderocol susceptibility and resistance mechanisms.
Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Oliver A; GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group. Sastre-Femenia MÀ, et al. Int J Antimicrob Agents. 2025 Oct;66(4):107563. doi: 10.1016/j.ijantimicag.2025.107563. Epub 2025 Jul 1. Int J Antimicrob Agents. 2025. PMID: 40609707
Regional distribution of carbapenemase-producing Acinetobacter baumannii isolates in southern Spain (Andalusia).
Fernández-Cuenca F, Rodríguez-Pallares S, López-Cerero L, Gutiérrez-Fernández J, Bautista MF, Sánchez Gómez JA, Sánchez-Yebra Romera W, Delgado M, Recacha E, Pascual A. Fernández-Cuenca F, et al. Among authors: recacha e. Eur J Clin Microbiol Infect Dis. 2025 May;44(5):1069-1076. doi: 10.1007/s10096-025-05047-2. Epub 2025 Feb 17. Eur J Clin Microbiol Infect Dis. 2025. PMID: 39961948 Free PMC article.
Broad spectrum of β-lactamase coverage and potent antimicrobial activity of xeruborbactam in combination with meropenem against carbapenemase-producing Enterobacterales, including strains resistant to new β-lactam/β-lactamase inhibitor combinations.
Sánchez-Peña L, Rodríguez-Pallares S, Aja-Macaya P, Blanco-Martín T, González-Pinto L, Pérez-Rodríguez G, Le Terrier C, Portillo-Calderón I, Recacha E, Riazzo C, Vázquez-Ucha JC, Beceiro A, Aracil B, Oteo-Iglesias J, Martínez-Martínez L, Poirel L, Bou G, Arca-Suárez J. Sánchez-Peña L, et al. Among authors: recacha e. Antimicrob Agents Chemother. 2025 Sep 3;69(9):e0053325. doi: 10.1128/aac.00533-25. Epub 2025 Jul 25. Antimicrob Agents Chemother. 2025. PMID: 40711423 Free PMC article.
Activity of imipenem-relebactam, ceftolozane-tazobactam and comparators against clinical isolates of Enterobacterales and Pseudomonas aeruginosa causing severe infections in hematological and oncological patients: A prospective multicenter study.
Cercenado E, Alcalá L, Irigoyen-von-Sierakowski Á, Rodríguez-Sánchez B, Marín M; GEIRAS-SEIMC Study Group. Cercenado E, et al. Int J Antimicrob Agents. 2025 Sep;66(3):107534. doi: 10.1016/j.ijantimicag.2025.107534. Epub 2025 May 8. Int J Antimicrob Agents. 2025. PMID: 40345344 Free article.
Identification and validation of clinical phenotypes in Staphylococcus aureus bloodstream infection and their association with mortality (FEN-AUREUS study).
Gutiérrez-Gutiérrez B, Gallego-Mesa B, Kaasch AJ, Riediger M, Rieg S, Trigo M, Salto-Alejandre S, Anguita-Santos F, Cano Á, Prolo-Acosta A, López-Cárdenas S, Pérez-Rodríguez MT, Martínez-Marcos FJ, Merino-Lucas E, Anaya-Baz B, Arizcorreta A, Plata-Ciézar A, Piscaglia M, Aceituno A, Romero-Calderón L, Hornuss D, Alemán-Rodríguez A, Gimeno-Gascón A, Recacha E, Torre-Cisneros J, Merchante N, Pascual Á, López-Cortés LE, Rodríguez-Baño J. Gutiérrez-Gutiérrez B, et al. Among authors: recacha e. EClinicalMedicine. 2025 May 7;83:103240. doi: 10.1016/j.eclinm.2025.103240. eCollection 2025 May. EClinicalMedicine. 2025. PMID: 40630616 Free PMC article.
Quinolone Resistance Reversion by Targeting the SOS Response.
Recacha E, Machuca J, Díaz de Alba P, Ramos-Güelfo M, Docobo-Pérez F, Rodriguez-Beltrán J, Blázquez J, Pascual A, Rodríguez-Martínez JM. Recacha E, et al. mBio. 2017 Oct 10;8(5):e00971-17. doi: 10.1128/mBio.00971-17. mBio. 2017. PMID: 29018116 Free PMC article.
28 results